- Home
- UHS vs RDY Comparison
UHS vs RDY Comparison
Compare UHS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- RDY
- Stock Information
- Founded
- UHS 1978
- RDY 1984
- Country
- UHS United States
- RDY India
- Employees
- UHS N/A
- RDY N/A
- Industry
- UHS Hospital/Nursing Management
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- UHS Health Care
- RDY Health Care
- Exchange
- UHS Nasdaq
- RDY Nasdaq
- Market Cap
- UHS 10.9B
- RDY 11.8B
- IPO Year
- UHS N/A
- RDY N/A
- Fundamental
- Price
- UHS $191.81
- RDY $14.65
- Analyst Decision
- UHS Hold
- RDY Strong Buy
- Analyst Count
- UHS 14
- RDY 2
- Target Price
- UHS $214.46
- RDY $16.95
- AVG Volume (30 Days)
- UHS 693.8K
- RDY 770.2K
- Earning Date
- UHS 10-23-2025
- RDY 11-04-2025
- Dividend Yield
- UHS 0.41%
- RDY 0.49%
- EPS Growth
- UHS 39.27
- RDY 2.20
- EPS
- UHS 18.95
- RDY 0.79
- Revenue
- UHS $16,460,285,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- UHS $9.65
- RDY $7.33
- Revenue Next Year
- UHS $4.89
- RDY $1.96
- P/E Ratio
- UHS $10.17
- RDY $18.74
- Revenue Growth
- UHS 9.61
- RDY 15.86
- 52 Week Low
- UHS $152.33
- RDY $12.26
- 52 Week High
- UHS $243.25
- RDY $16.19
- Technical
- Relative Strength Index (RSI)
- UHS 67.83
- RDY 59.74
- Support Level
- UHS $180.55
- RDY $14.54
- Resistance Level
- UHS $190.82
- RDY $14.35
- Average True Range (ATR)
- UHS 3.96
- RDY 0.15
- MACD
- UHS 0.50
- RDY 0.06
- Stochastic Oscillator
- UHS 89.90
- RDY 85.29
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.